Ilan Neugarten

Executive Chairman of Rainbow Medical and Chairman of the Board of GluSense

Mr. Neugarten has over 35 years of senior managerial experience and over 15 years of experience in the medical industry. He brings to Rainbow Medical significant experience in medical device venture capital investments, commercialization, and asset realization. Mr. Neugarten joined the Viola Partners Group in 2000 as a partner of DOR Ventures, a VC fund focusing on imaging technologies. During his period at DOR Ventures, he led various investments including medical imaging ventures. Since 2006, he led the healthcare investments of Viola Partners and currently serves on the boards of Angioslide, NanoPass, and PainReform. Prior to joining the Viola Partners Group, he worked for Scitex (NASDAQ:SCIX) in various management positions in Europe, Japan, and Israel.
Mr. Neugarten received his BSc in Electronics from the Technion, Haifa Israel, and an MBA from Boston University.